Orphan Drugs: the Conundrum- Clinical Research Trials 2015

Orphan Drugs: the Conundrum- Clinical Research Trials 2015 is an event dedicated to orphan drugs.

Key Topics

• Role of the FDA
• Definition of the Orphan Drug Act
• Why the varying views
• Understanding why the Orphan Drug Act has started a conundrum
• Competing in the Rare Disease Space
• Good Intentions, Bad Results
• Comparison of Rare Disease Drugs VS other drugs
• Review of drugs passed that are Orphan Drugs
• Benefits of the Orphan Drug Act VS drawbacks

Who should Attend

Attendees from:

• Director of Human Resource
• Benefit Managers
• Director of Strategy
• Director of Access
• Representatives of Purchasers
• Pharmacy Benefit Managers
• Consumer Organization Representatives
• Private Employers and Public Purchasers
• Health Care Regulators and Policy Makers
• Federal and State Government Officials
• Health Services Researchers and Academics
• Health Benefits Consultants
• Director of Accountable Care
• Chief Innovation Officers
• Director of Government Programs
• Directors of Quality Management
• Director of Medicaid Programs
• Director of Medicare Programs
• Director of Provider Relations
• Director of Network Contracting
• Pharmaceutical Executives
• Director of Reimbursement
• Director of Patient Advocacy
• Pharmaceutical Consultants
• Electronic Health Record Staff and Venders
• Pharmacy Benefit Manager